Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations

by Ahn M.J.
Published 2023

Will the requirement by the US FDA to simultaneously co-develop companion diagnostics (CDx) delay the approval of receptor tyrosine kinase inhibitors for RTK-rearranged (ROS1-, RET...

by Ou, S.-H.I, Soo, R.A, Kubo, A, Kawaguchi, T, Ahn, M.-J
Published 2020

An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung canc...

by Chang J.W.-C., Thongprasert S., Wright E., Tsang K., Kim H.T., Ahn M.-J., Kim J.-H., Kang J.H., Kim S.-W., Walzer S.
Published 2014

Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck

by Huang, K.K, Jang, K.W, Kim, S, Kim, H.S, Kim, S.-M, Kwon, H.J, Kim, H.R, Yun, H.J, Ahn, M.J, Park, K.U, Ramnarayanan, K, McPherson, J.R, Zhang, S, Rhee, J.-K, Vettore, A.L, Das, K, Ishimoto, T, Kim, J.H, Koh, Y.W, Kim, S.H, Choi, E.C, Teh, B.T, Rozen, S.G, Kim, T.-M, Tan, P, Cho, B.C
Published 2020

A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lun...

by Soh, S.X, Siddiqui, F.J, Allen, J.C, Kim, G.W, Lee, J.C, Yatabe, Y, Soda, M, Mano, H, Soo, R.A, Chin, T.-M, Ebi, H, Yano, S, Matsuo, K, Niu, X, Lu, S, Isobe, K, Lee, J.-H, Yang, J.C, Zhao, M, Zhou, C, Lee, J.-K, Lee, S.-H, Lee, J.Y, Ahn, M.-J, Tan, T.J, Tan, D.S, Tan, E.-H, Ong, S.T, Lim, W.-T
Published 2020